Advertisement
Advertisement
MOLN
Molecular Partners AG - ADR
4.29
USDSponsored
-0.02
-0.35%
Mar 26, 15:58 UTC -4
Closed
After-Market
4.22
-0.08
-1.75%
MOLN Earnings Reports
Positive Surprise Ratio
MOLN beat 4 of 4 last estimates.
100%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Molecular Partners AG - ADR earnings per share and revenue
On Mar 12, 2026, MOLN reported earnings of -0.23 USD per share (EPS) for Q4 25, beating the estimate of -0.34 USD, resulting in a 32.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.40% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
FAQ
What were Molecular Partners AG - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Molecular Partners AG - ADR reported EPS of -$0.23, beating estimates by 32.53%, and revenue of $0.00, 0% as expectations.
How did the market react to Molecular Partners AG - ADR's Q4 2025 earnings?
The stock price moved down -10.4%, changed from $4.71 before the earnings release to $4.22 the day after.
When is Molecular Partners AG - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Molecular Partners AG - ADR's next earnings report?
Based on --
analysts, Molecular Partners AG - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement